In order-to minimize COVID-19 spread, authorities worldwide have ordered stringent lockdown measures.1 This necessary measure limiting physical activity (PA) results in increasing sedentary time (SEDTime), stress and glycaemic variability. COVID-19 has highlighted the major vulnerability of populations with pre-existing comorbidities.2 Type 2 diabetes mellitus (T2DM) is a major comorbidity for COVID- 19 progression and adverse endpoints, and well-controlled blood glucose is associated with a significant reduction in the composite of adverse outcomes and death.3,4 In a T2DM patients, with or without COVID-19, the goal remain to achieve optimal glycaemic control. To date, it is unclear if good glycaemic control in a T2DM outpatient setting is sufficient to prevent COVID-19, but glycaemic control with a HbA1c <7% and plasma glucose variability maintained between 72 and 144 mg/dL could reduce the risk of infections that might lead to hospitalizations.5,6 Such patients setting, if fit, might well benefit from maintained PA, and if sedentary and unfit, would greatly benefit from increased PA and reducing SED-Time.7 There are solid evidence that moderate combined aerobic and resistance training programmes are effective in improving daily glucose control, haemoglobin A1c levels and modifiable cardiovascular risk factors in sedentary subjects with T2DM8 as well as improving mental health-related quality of life wellbeing.